MAGEA3 and cancer: First, while we focused on establishing the biomarker potential of MAGEA3, mechanistic studies using functional mouse models would provide additional insights into how MAGEA3 influences bevacizumab efficacy in the tumor microenvironment, and may open a new avenue for targeting MAGEA3 in cancer treatment.